<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-25-02529-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-25-02529-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Approved and under-trial protease inhibitors.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protease</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inhibitors</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>HIV-1 Protease</bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">amprenavir, atazanavir, brecanavir, darunavir, droxinavir, fosamprenavir, indinavir, lasinavir, lopinavir, mozenavir, nelfinavir, palinavir, ritonavir, saquinavir, telinavir, and tipranavir</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>HCV Protease</bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">asunaprevir, boceprevir, ciluprevir, danoprevir, faldaprevir, narlaprevir, neceprevir, simeprevir, sovaprevir, telaprevir, vaniprevir, and vedroprevir</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Dipeptidyl Peptidase-4 (DPP-4)</bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">alogliptin, anagliptin, bisegliptin, carmegliptin, denagliptin, dutogliptin, evogliptin, gemigliptin, gosogliptin, linagliptin, melogliptin, omarigliptin, saxagliptin, sitagliptin, teneligliptin, trelagliptin, and vildagliptin</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Renin</bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">aliskiren, ciprokiren, ditekiren, enalkiren, remikiren, terlakiren, and zankiren</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>ACE</bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">alacepril, benazepril, captopril, ceronapril, cilazapril, delapril, enalapril, fosinopril, idrapril, imidapril, indolapril, libenzapril, lisinopril, moexipril, moveltipril, orbutopril, pentopril, perindopril, pivopril, quinapril, ramipril, rentiapril, spirapril, temocapril, trandolapril, utibapril, zabicipril, and zofenopril</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Thrombin</bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">direct inhibitors: argatroban, inogatran, melagatran and its pro-drug ximelagatran, and dabigatran [
     <xref rid="B30-molecules-25-02529" ref-type="bibr">30</xref>,
     <xref rid="B31-molecules-25-02529" ref-type="bibr">31</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Coagulation Factor Xa</bold>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rivaroxaban, apixaban, betrixaban, darexaban, edoxaban, otamixaban, and letaxaban</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
